This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Ben-Fillippo Krippendorff: Innovator in Antibody Development
Introduction
Ben-Fillippo Krippendorff is a notable inventor based in Loerrach, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the creation of a patent that addresses important medical applications.
Latest Patents
Krippendorff holds a patent for "Anti-TPBG antibodies and methods of use." This invention provides anti-TPBG antibodies and outlines methods for utilizing them effectively. The patent represents a significant advancement in therapeutic options for various medical conditions.
Career Highlights
Ben-Fillippo Krippendorff is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His role at the company allows him to further his research and development efforts in antibody technology. With a total of 1 patent, he has established himself as a valuable contributor to the field.
Collaborations
Throughout his career, Krippendorff has collaborated with esteemed colleagues, including Stefan Dengl and Sebastian Fenn. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Ben-Fillippo Krippendorff's work in the development of anti-TPBG antibodies showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches and highlight the importance of innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile